Key result
Multimodal diagnostics including ECG, echo, CMR, and genetics detect early-stage HCM in an asymptomatic athlete.
Why the study?
HCM is often asymptomatic early on but remains a leading cause of sudden cardiac death in young athletes, making detection of subtle manifestations during routine screening vital to prevent adverse outcomes.
Case Report (n=1)
A multimodal diagnostic approach including CMR and genetic testing is critical for identifying and risk-stratifying early-stage, high-risk hypertrophic cardiomyopathy in asymptomatic athletes following abnormal routine screening.
No takes yet. Share an insight, caveat, or question.
May warrant multimodal evaluation after abnormal athlete screening; leaves open generalizability and outcome impact.
Magnano et al. (2026) conducted a case report in Hypertrophic cardiomyopathy (n=1). Multimodal diagnostic approach (ECG, echocardiography, CMR, genetic testing) was evaluated on Diagnosis of hypertrophic cardiomyopathy. A multimodal diagnostic approach including ECG, echocardiography, CMR, and genetic testing successfully identified early-stage hypertrophic cardiomyopathy in a completely asymptomatic 24-year-old athlete.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: